Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Nomi New Medical Technology

Request full access

Nanos Medical is a Healthcare Company

Huangpu, ChinaFounded 2015Health Tech & Medtech

About Nomi New Medical Technology

Nomi New Medical Technology, officially known as Nanos Medical (Shanghai) Limited, is a Chinese medical device company established in 2015 with its headquarters in Shanghai. The company was founded by Terry Cui, who serves as the chairman. Cui's background is not in medicine but in business and investment; after an early entrepreneurial success, he studied at the Wharton School of the University of Pennsylvania, worked as a consultant for Boston Consulting Group, and was a Vice President at CITIC Capital, focusing on healthcare investments. This experience informed the rational, business-driven decision to enter the Ear, Nose, and Throat (ENT) medical device sector.

The company's strategic growth is propelled by a three-pronged approach: in-house research and development, licensing-in foreign technologies, and mergers and acquisitions. This strategy has led to significant expansion, including the establishment of an R&D and manufacturing base in Suzhou in 2017 and a series of key acquisitions. Notable acquisitions include Chengdu Mechan, a medical plasma technology platform, in 2019; a controlling stake in Hangzhou Tonglu Sike Medical Instrument Co. in 2021; and the complete acquisition of German endoscopy system manufacturer Endodoctor in 2022. These moves have contributed to a compound annual growth rate of over 200% in the past five years and have transformed the firm from a startup into a group company with an international footprint.

Nanos Medical develops, manufactures, and sells a comprehensive portfolio of medical devices focused on otorhinolaryngology (ENT) and minimally invasive surgery, serving hospitals and clinics. The business model integrates R&D, production, and sales to provide a full range of diagnostic and treatment solutions. Its product line is extensive, featuring items such as a Low-Temperature Plasma Surgery System, sinus balloon catheters, eustachian tube balloons, drug-eluting stents, and various surgical instruments. The company also acts as a commercial transformation platform, introducing advanced international technologies into the Chinese market, such as Korean ENT diagnostic units and Swedish rhinitis treatment instruments. Revenue is generated through the sale of these devices and systems to medical institutions.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
18.0/100
Industry
Health
Sub-industry
Health Platform
Sector
Hospital, Hard Tech
Client focus
B2B
Links
Website

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Feb 2025 $41M $165M River Head Capital · Qiming Venture Partners ↗
SERIES B✓Equity / VC Jul 2019 $0 — Eight Roads Ventures —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Nomi New Medical Technology website traffic

Latest recorded traffic for Nomi New Medical Technology is 2.2K monthly website visits, down 8.3% over the last three months.

Latest monthly visits2.2K 3-month web change-8.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Nomi New Medical Technology in the Huangpu ecosystem

Live from Dealroom

The Nomi New Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later2 investors entered at this stage

Other known investors2 additional known investors

Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Huangpu HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Nomi New Medical Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nomi New Medical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.